We are monitoring the impact of COVID-19 on APAC Contraceptives Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1157
Share on
Share on

Asia Pacific Contraceptives Market Research Report – Segmented By Drug Type, Medical Devices, End-Users, Country (India, China, Japan, Australia, New Zealand, ASEAN Countries and Rest of APAC) - Industry Analysis, Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1157
Pages: 136

APAC Contraceptives Market Size (2021 to 2026)

As per our report, the Asia Pacific Contraceptives Market size was worth USD 5.74 billion in 2021 and estimated to reach USD 8.04 billion by the end of 2026, with a growing potential of 6.95%.

The need to avoid unplanned pregnancies and associated consequences are the key drivers driving the APAC contraceptives market. Therefore, the desire to avoid unintended pregnancies, particularly among young girls, is one of the major drivers of this market. It is more commonly referred to as fertility control or birth control, which is defined as preventing conception.

Moreover, the government initiatives and spreading awareness related to controlling the increasing population, its effects, and side effects can also be the reason for the market growth of contraceptives. In addition, non-contraceptive health advantages, including therapy for heavy menstrual bleeding, menstrual discomfort, and acne, are also cited by more than half of the women as reasons for usage; this can also drive the market's expansion.

The adverse side effects of the contraceptives, which include dizziness, irregular menstrual bleeding and causing of infertility, high cost of treatment, and availability of alternative contraceptives, can adversely affect the market growth of the contraceptives in this region.

Impact of COVID-19 on the APAC contraceptives market:

The COVID-19 epidemic has impacted negatively on healthcare services and technology around the world. It disrupted the demand and supply chain. Due to this pandemic, proper health care facilities and services were not available, as supply chains get disrupted, there were limited availability of contraceptives with product shortage and stockouts, lack of trained workers, and due to the lack of personal protective equipment to provide safe services, also due to the fear of COVID-19.

This research report on the APAC Contraceptives Market has been segmented & sub-segmented into the following categories:

By Drug Type: 

  • Contraceptive Pills
  • Topical Contraceptives
  • Contraceptive Injectable
  • Others (Contraceptive Gels, Jellies, and Creams)

By Medical Devices: 

  • Male Contraceptive Devices (Condoms)
  • Female Contraceptive Devices
    • Female Condoms
    • Intrauterine Devices
      • Hormonal IUD’s
      • Copper IUD’s
  • Contraceptive Sponges
  • Contraceptive Diaphragms
  • Subdermal Contraceptive Implants
  • Contraceptive Patches
  • Non-Surgical Permanent Contraceptive Devices

By End User: 

  • Hospitals
  • Home Care
  • Clinics
  • Ambulatory Surgical Centres

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, Asia Pacific profoundly influenced the industry in terms of demographics and lack of awareness within the large population. Favorable government initiatives about sex education are major factors expected to boost the contraceptives market growth over the forecast period.

The Indian Contraceptives Devices market is expected to grow at a CAGR of 7.42% during the forecast period. The need to decrease unwanted births and their repercussions is one of the main drivers driving the growth of the contraceptive business in India.  One of the main causes of this demand is the desire to avoid unintended births, especially among young girls. However, non-contraceptive medical advantages, including medicine for extended menstrual bleeding, menstrual cramps, and acne, are also seen by less than half of women as motivations for usage.

The China Contraceptives Market is estimated to grow at a CAGR of about 7.98% during the forecast period. The factors such as rising instances of sexually transmitted illnesses and climbing in the government efforts to prevent these diseases can result in a growing need for preventative measures in such illnesses, which is likely to drive up demand for contraceptive devices. In addition, earlier China has also come up with the one-child policy to control its increasing population.

Also, countries such as Japan and Australia are estimated to grow healthy growth rates during the forecast period. The increased awareness of sexually transmitted diseases and the rising prevalence of unplanned pregnancies are the reasons that are propelling the industry forward and are responsible for the market growth.

KEY MARKET PLAYERS:

A few of the notable companies dominating the APAC contraceptives market are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Drug type                              

                                5.1.1 Contraceptive pills               

                                5.1.2 Topical contraceptives       

                                5.1.3 Contraceptive injectable   

                                5.1.4 Others (contraceptive gels, jellies and creams)        

                5.2 By Medical Devices                 

                                5.2.1 Male contraceptive devices             

                                5.2.2 Female contraceptive devices        

                                                5.2.2.1 Female condoms

                                                5.2.2.2 Intrauterine devices

                                                5.2.2.3 Contraceptive sponges

                                                5.2.2.4 Contraceptive diaphragms

                                                5.2.2.5 Contraceptive patches

                                                5.2.2.6 Subdermal contraceptive implants

                                                5.2.2.7 Non-surgical permanent contraceptive devices

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 China            

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bayer HealthCare AG                             

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Teva Pharmaceutical Industries Limited                         

                8.3 Medisafe Distribution Inc                     

                8.4 Pace Pharmaceuticals Inc                     

                8.5 Medicines360                            

                8.6 Church & Dwight, Co., Inc.                   

                8.7 Actavis, Inc                 

                8.8 CooperSurgical                         

                8.9 Merck & Co., Inc                       

                8.10 Reckitt Benckiser plc                            

                8.11 Mayer Laboratories, Inc                      

                8.12 Pfizer, Inc                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Market outlook and Investment oppurtunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Contraceptives Market By Drug type, From 2021 to 2026 (USD Million)
  2. Asia-Pacific Contraceptive pills Market By Region, From 2021 to 2026 (USD Million)
  3. Asia-Pacific Topical contraceptives Market By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific Contraceptive injectable Market By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific Contraceptives Market By Medical Devices, From 2021 to 2026 (USD Million)
  6. Asia-Pacific Male Contraceptive devices Market By Region, From 2021 to 2026 (USD Million)
  7. Asia-Pacific Female Contraceptive devices Market By Region, From 2021 to 2026 (USD Million)
  8. Asia-Pacific Contraceptives Market By End users, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Hospitals Market By Region, From 2021 to 2026 (USD Million)
  10. Asia-Pacific Home care Market By Region, From 2021 to 2026 (USD Million)
  11. Asia-Pacific Clinics Market By Region, From 2021 to 2026 (USD Million)
  12. Asia-Pacific Ambulatory Surgical Centres Market By Region, From 2021 to 2026 (USD Million)
  13. Japan Contraceptives Market By Drug type, From 2021 to 2026 (USD Million)
  14. Japan Contraceptives Market By Medical Devices, From 2021 to 2026 (USD Million)
  15. Japan Contraceptives Market By End users, From 2021 to 2026 (USD Million)
  16. China Contraceptives Market By Drug type, From 2021 to 2026 (USD Million)
  17. China Contraceptives Market By Medical Devices, From 2021 to 2026 (USD Million)
  18. China Contraceptives Market By End users, From 2021 to 2026 (USD Million)
  19. India Contraceptives Market By Drug type, From 2021 to 2026 (USD Million)
  20. India Contraceptives Market By Medical Devices, From 2021 to 2026 (USD Million)
  21. India Contraceptives Market By End users, From 2021 to 2026 (USD Million)
  22. Asia-Pacific Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  23. Asia-Pacific female condoms Market By Region, From 2021 to 2026 (USD Million)
  24. Asia-Pacific intrauterine devices Market By Region, From 2021 to 2026 (USD Million)
  25. Asia-Pacific contraceptive sponges Market By Region, From 2021 to 2026 (USD Million)
  26. Asia-Pacific contraceptive diaphragms Market By Region, From 2021 to 2026 (USD Million)
  27. Asia-Pacific contraceptive patches Market By Region, From 2021 to 2026 (USD Million)
  28. Asia-Pacific subdermal contraceptive implants Market By Region, From 2021 to 2026 (USD Million)
  29. Asia-Pacific non-surgical permanent contraceptive devices Market By Region, From 2021 to 2026 (USD Million)
  30. Japan Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  31. China Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  32. India Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  33. Asia-Pacific Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  34. Asia-Pacific female condoms Market By Region, From 2021 to 2026 (USD Million)
  35. Asia-Pacific intrauterine devices Market By Region, From 2021 to 2026 (USD Million)
  36. Asia-Pacific contraceptive sponges Market By Region, From 2021 to 2026 (USD Million)
  37. Asia-Pacific contraceptive diaphragms Market By Region, From 2021 to 2026 (USD Million)
  38. Asia-Pacific contraceptive patches Market By Region, From 2021 to 2026 (USD Million)
  39. Asia-Pacific subdermal contraceptive implants Market By Region, From 2021 to 2026 (USD Million)
  40. Asia-Pacific non-surgical permanent contraceptive devices Market By Region, From 2021 to 2026 (USD Million)
  41. Japan Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  42. China Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  43. India Contraceptives Market, By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  44. Asia-Pacific Contraceptives Market, By Intrauterine devices, From 2021 to 2026 (USD Million)
  45. Asia-Pacific Hormonal IUD's Market By Region, From 2021 to 2026 (USD Million)
  46. Japan Contraceptives Market, By Intrauterine devices, From 2021 to 2026 (USD Million)
  47. China Contraceptives Market, By Intrauterine devices, From 2021 to 2026 (USD Million)
  48. India Contraceptives Market, By Intrauterine devices, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample